p21 can be a barrier to ferroptosis independent of p53

被引:0
|
作者
Venkatesh, Divya [1 ]
Stockwell, Brent R. [1 ,2 ]
Prives, Carol [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[2] Columbia Univ, Dept Chem, New York, NY 10027 USA
来源
AGING-US | 2020年 / 12卷 / 18期
关键词
p21; ferroptosis; cancer; p53-independent; organ damage; CELL-DEATH; TUMOR-SUPPRESSOR; DOWN-REGULATION; PHOSPHORYLATION; INACTIVATION; METABOLISM; SENESCENCE; RESISTANCE; POTENCY; DISEASE;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Traditionally, the p21 protein has been viewed as limiting cancer progression and promoting aging. In contrast, there are reports that p21 can enhance cancer survival and limit tissue damage, depending on the tissue of origin and type of stressor involved. Here, we provide evidence to support these latter two roles of p21 by exploring its ability to regulate ferroptosis. Ferroptosis is a form of cell death that is associated with certain degenerative diseases, some of which are aging-related. Our results reveal a correlation between p21 protein levels in cell lines that are resistant to ferroptosis (p21 high) versus cell lines that are sensitive and easily undergo ferroptosis (p21 low). We also show that p21 levels themselves are differentially regulated in response to ferroptosis in a p53-independent manner. Further, experimentally altering the abundance of p21 protein inverts the ferroptosis-sensitivity of both resistant and sensitive human cancer cell lines. Our data also indicate that the interaction of p21 with CDKs is crucial for its ability to restrict the progression of ferroptosis. While this study was performed in cancer cell lines, our results support the potential of p21 to aid in maintenance of healthy tissues by blocking the damage incurred due to ferroptosis.
引用
收藏
页码:17800 / 17814
页数:15
相关论文
共 50 条
  • [41] Association of p21, p21 p27 and p21 p53 Status to Histological Subtypes and Prognosis in Low-stage Epithelial Ovarian Cancer
    Skirnisdottir, Ingiridur
    Seidal, Tomas
    CANCER GENOMICS & PROTEOMICS, 2013, 10 (01) : 27 - 34
  • [42] Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent
    Chen, TG
    Turner, J
    McCarthy, SC
    Scaltriti, M
    Bettuzzi, S
    Yeatman, TJ
    CANCER RESEARCH, 2004, 64 (20) : 7412 - 7419
  • [43] The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter site
    Garcia-Alai, Maria M.
    Tidow, Henning
    Natan, Eviatar
    Townsley, Fiona M.
    Veprintsev, Dmitry B.
    Fersht, Alan R.
    PROTEIN SCIENCE, 2008, 17 (10) : 1671 - 1678
  • [44] 14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53
    Lee, Jun-Ho
    Lu, Hua
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) : 5136 - 5142
  • [45] Senescence Process in Primary Wilms' Tumor Cell Culture Induced by p53 Independent p21 Expression
    Theerakitthanakul, Korkiat
    Saetang, Jirakrit
    Kruatong, Jirasak
    Graidist, Potchanapond
    Raungrut, Pritsana
    Kayasut, Kanita
    Sangkhathat, Surasak
    JOURNAL OF CANCER, 2016, 7 (13): : 1867 - 1876
  • [46] Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21
    Nakanishi, Y
    Pei, XH
    Takayama, K
    Bai, F
    Izumi, M
    Kimotsuki, K
    Inoue, K
    Minami, T
    Wataya, H
    Hara, N
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (06) : 747 - 754
  • [47] Deletion of p21 can not substitute for p53 loss in rescue of mdm2 null lethality
    Luna, RMD
    Amelse, LL
    ChavezReyes, A
    Evans, SC
    Brugarolas, J
    Jacks, T
    Lozano, G
    NATURE GENETICS, 1997, 16 (04) : 336 - 337
  • [48] Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease
    Lee, Yao-Ling
    Chen, Wei
    Tsai, Wen-Kai
    Lee, Jen-Chih
    Chiou, Hui-Ling
    Shih, Chuen-Ming
    Wang, Yi-Ching
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2006, 147 (05): : 228 - 233
  • [49] 焦炉工外周血P21、P53蛋白的检测
    张太江
    马永志
    肖文
    张俊萍
    王诗斌
    张巧
    职业与健康, 2003, (10) : 40 - 41
  • [50] Gene therapy with p53 or p21 adenovirus for hepatocellular carcinoma.
    Kanai, F
    Ikenoue, T
    Ohashi, M
    Tanaka, T
    Lan, KH
    Ueno, H
    Yoshida, H
    Kawabe, T
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1296 - A1296